The efficacy of one of the Iranian Traditional Remedy on spermogram in infertile me
- Conditions
- Infertility.Diseases of male genital organs,Male infertility,
- Registration Number
- IRCT2015100624377N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 43
Men 20-45 years
Infertility for at least one year
Unexplained Oligo-astheno-teratozoospermia according to WHO criteria: Sperm concentrations below 20 million per milliliter; 5. Motile sperm less than 50%; 6. The normal morphology less than 30%
History of taking chemotherapy, Corticosteroid, Anticoagulation, Testosterone, Antiandrogen
The incidence of severe cases of oligospermia (sperm concentration less than one million per milliliter)
Infections, genital anatomical abnormalities, chromosomal abnormalities, history of surgery on the genital tract, exposure to toxins
Alcohol or drug abuse
Systemic diseases (cancer, thyroid disease, liver and gall bladder diseases, renal failure, etc.)
The reluctance of patients to continue
Make any side effects from medication
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Semen volume. Timepoint: At the begining of the trial, 3 months after end of the drug. Method of measurement: Semen analysis.;Sperm count. Timepoint: At the begining of the trial, 3 months after end of the drug. Method of measurement: Sperm analysis.;Sperm motility. Timepoint: At the begining of the trial, 3months after end of the drug. Method of measurement: Semen analysis.;Normal morphology. Timepoint: At the begining of the trial, 3months after end of the dru. Method of measurement: Semen analysis.
- Secondary Outcome Measures
Name Time Method Fertility. Timepoint: After treatment. Method of measurement: Partner pregnancy.;Side effects such as itching, etc. Timepoint: During the intervention. Method of measurement: Patient report.